Actividades
Recursos sobre trasplantes
Trasplante cardiaco: Artículos interesantes

Eghtesady P, Almond CS, Tjossem C, Epstein D, Imamura M, Turrentine M, Tweddell J, Jaquiss RD, Canter C; Berlin Heart Investigators. Post-transplant Outcomes of Children Bridged to Transplant With the Berlin Heart EXCOR Pediatric Ventricular Assist Device. Circulation 2013 Sep 10; 128 (26 Suppl 1): S24-31.

González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, López-Granados A, Escribano P, Farrero M. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant 2013 Sep 12.

Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. J Heart Lung Transplant 2013 Aug 29. doi:pii: S1053-2498(13)01376-4. 10.1016/j.healun.2013.08.002. [Epub ahead of print]

Jaramillo N, Segovia J, Gómez-Bueno M, García-Cosío D, Castedo E, Serrano S, Burgos R, García Montero C, Ugarte J, Martínez Cabeza P, Alonso-Pulpón L. Characteristics of Patients With Survival Longer Than 20 Years Following Heart Transplantation. Rev Esp Cardiol 2013 Aug 6.

Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, González-Vilchez F, Villa-Arranz A, Delgado-Jiménez J, Lage-Galle E, Pérez-Villa F, Lambert-Rodríguez JL, Manito-Lorite N, Arizon-Del Prado JM, Brossa-Loidi V, Pascual-Figal D, Fuente-Galán L de L, Sanz-Julve M, Muñiz-García J, Crespo-Leiro M. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail 2013 Jul;6(4):763-72.

Melero-Ferrer JL, Sánchez-Lázaro IJ, Almenar-Bonet L, Martínez-Dolz L, Buendía-Fuentes F, Portolés-Sanz M, Rivera-Otero M, Salvador-Sanz A. Impact of basal heart rate on long-term prognosis of heart transplant patients. Transpl Int 2013 May; 26 (5): 502-7.

Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant 2013 May; 13 (5): 1203-16.

Bhama JK, Shulman J, Bermudez CA, Bansal A, Ramani R, Teuteberg JJ, Shullo M, McNamara DM, Kormos RL, Toyoda Y. Heart transplantation for adults with congenital heart disease: results in the modern era. J Heart Lung Transplant 2013 May; 32

Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant 2013 May; 32 (5): 492-8.

Zuckermann A, Wang SS, Epailly E, Barten MJ, Sigurdardottir V, Segovia J, Varnous S, Turazza FM, Potena L, Lehmkuhl HB. Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now? Transplant Rev (Orlando) 2013 May.

Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P. Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial. Am J Transplant 2013 Feb 22. doi: 10.1111/ajt.12181. [Epub ahead of print]

Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. Transplantation 2013 Feb 27; 95 (4): 629-34

Paniagua Martín MJ, Almenar L, Brossa V, Crespo-Leiro MG, Segovia J, Palomo J, Delgado J, González-Vílchez F, Manito N, Lage E, García-Guereta L, Rodríguez-Lambert JL, Albert DC. Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry. Clin Transplant 2012 Sep-Oct; 26 (5): 755-6

Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant 2012 Sep; 12 (9): 2487-97

Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency

HLA desensitization in pediatric heart transplant candidates: Efficacy of rituximab and IVIg

Pregnancy after cardiac transplantation

Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation

Statins and the risk of cancer after heart transplantation

Heart transplantation: organisational aspects and current trends in immunosuppression--a view from Spain

A Simple Score to Assess the Risk of Rejection Following Orthotopic Heart Transplantation

Working Group Participants. Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group

Trends in the Indications and Survival in Pediatric Heart Transplants: A 24-year Single-Center Experience in 307 Patients

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

Heart transplantation: organisational aspects and current trends in immunosuppression--a view from Spain

Cardiac amyloidosis: what are the indications for transplant?

Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation

Usefulness of high sensitivity troponin T assay in detecting acute allograft rejection after heart transplantation

RADIAL: a novel primary graft failure risk score in heart transplantation

Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation

T cells in Cardiac Allograft Vasculopathy Are Skewed to Memory Th-1 Cells in the Presence of a Distinct Th-2 Population

Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis

Prevalence and Risk Factors for Tricuspid Valve Regurgitation After Pediatric Heart Transplantation

Foxp3-expressing Regulatory T Cells Expanded With CD28 Superagonist Antibody Can Prevent Rat Cardiac Allograft Rejection

Development of a Combined Heart and Carotid Artery Transplant Model to Investigate the Impact of Acute Rejection on Cardiac Allograft Vasculopathy

Myocardial Pro-inflammatory Cytokine Expression and Cellular Rejection in Pediatric Heart Transplant Recipients

Limited utility of endomyocardial biopsy in the first year after heart transplantation

Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation

Granulocyte colony-stimulating factor prevents reperfusion injury after heart preservation

Effect of infectious diseases on outcome after heart transplant

The complex role of iNOS in acutely rejecting cardiac transplants

Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database